CI The Cigna Group Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026CI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
CI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| June 5, 2007 | 3-for-1 | Forward |
| May 18, 1998 | 3-for-1 | Forward |
About The Cigna Group Common Stock Company overview from Wikipedia
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 11.25Y avg ≈16.5 | ≈16.5 | 23.3 | Undervalued | |
| P/S | 0.35Y avg ≈0.4 | ≈0.4 | 1.3 | Undervalued | |
| P/B | 1.75Y avg ≈1.9 | ≈1.9 | 2.9 | Undervalued | |
| EV / EBITDA | 5.25Y avg ≈6.5 | ≈6.5 | 11.4 | Undervalued | |
| Price / Cash Flow | 7.45Y avg ≈8.8 | ≈8.8 | 9.8 | Undervalued | |
| EV / Revenue | 0.25Y avg ≈0.4 | ≈0.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 3.5%5Y avg ≈4.2% | ≈4.2% | 8.3% | Weak | |
| EBITDA Margin (TTM) | 4.5%5Y avg ≈5.5% | ≈5.5% | 8.8% | Weak | |
| Pretax Margin (TTM) | 3.1%5Y avg ≈3.3% | ≈3.3% | 3.8% | Weak | |
| Net Profit Margin (TTM) | 2.2%5Y avg ≈2.7% | ≈2.7% | 5.1% | Weak | |
| ROA (TTM) | 4.0%5Y avg ≈3.6% | ≈3.6% | 4.0% | In line | |
| ROE (TTM) | 15.0%5Y avg ≈12.1% | ≈12.1% | 12.5% | In line | |
| ROIC | 17.8%5Y avg ≈15.9% | ≈15.9% | 9.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.05Y avg ≈0.0 | ≈0.0 | 0.4 | Low debt | |
| Current Ratio (MRQ) | 0.85Y avg ≈0.8 | ≈0.8 | 1.4 | Low liquidity | |
| Quick Ratio (MRQ) | 0.75Y avg ≈0.6 | ≈0.6 | 0.8 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 11.2%5Y avg ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y | 15.0%5Y avg ≈11.4% | ≈11.4% | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | |
| EPS YoY | 83.0%5Y avg ≈7.7% | ≈7.7% | · | · | |
| Net Income YoY | 73.5%5Y avg ≈1.0% | ≈1.0% | · | · | |
| EPS CAGR 3Y | 1.2%5Y avg ≈-5.3% | ≈-5.3% | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | |
| Net Income CAGR 3Y | -4.2%5Y avg ≈-11.2% | ≈-11.2% | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.85Y avg ≈1.4 | ≈1.4 | 1.2 | Top tier | |
| Inventory Turnover | 30.65Y avg ≈29.9 | ≈29.9 | 15.6 | Top tier | |
| Receivables Turnover | 10.45Y avg ≈11.5 | ≈11.5 | 10.5 | In line | |
| Revenue / Employee | ≈$4.2M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 8, 2026 | $1.56 | USD | ≈2.2% |
| Jun 4, 2026 | $1.56 | USD | ≈2.2% |
| Mar 5, 2026 | $1.56 | USD | ≈2.2% |
| Dec 4, 2025 | $1.51 | USD | ≈2.3% |
| Sep 4, 2025 | $1.51 | USD | ≈2.0% |
| Jun 3, 2025 | $1.51 | USD | ≈1.9% |
| Mar 5, 2025 | $1.51 | USD | ≈1.8% |
| Dec 4, 2024 | $1.40 | USD | ≈1.7% |
| Sep 4, 2024 | $1.40 | USD | ≈1.5% |
| Jun 4, 2024 | $1.40 | USD | ≈1.6% |
| Mar 5, 2024 | $1.40 | USD | ≈1.5% |
| Dec 5, 2023 | $1.23 | USD | ≈1.9% |
| Sep 5, 2023 | $1.23 | USD | ≈1.7% |
| Jun 6, 2023 | $1.23 | USD | ≈1.8% |
| Mar 7, 2023 | $1.23 | USD | ≈1.6% |
| Dec 5, 2022 | $1.12 | USD | ≈1.4% |
| Sep 6, 2022 | $1.12 | USD | ≈1.5% |
| Jun 7, 2022 | $1.12 | USD | ≈1.6% |
| Mar 8, 2022 | $1.12 | USD | ≈1.8% |
| Dec 6, 2021 | $1.00 | USD | ≈1.9% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 29, 2026 | $7.78 | $7.83 | -0.59% |
| March 31, 2026 | $7.79 | $7.84 | -0.65% | |
| Dec. 31, 2025 | $8.08 | $8.11 | -0.41% | |
| Sept. 30, 2025 | $7.83 | $7.88 | -0.60% | |
| June 30, 2025 | $7.20 | $7.37 | -2.3% | |
| March 31, 2025 | $6.74 | $6.54 | 3.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $158.33 | $149.87 | $158.03 | $150.24 | $145.88 | $141.84 | $121.70 | $107.71 | · | · | |
| Revenue / Share | $1023.60 | $872.55 | $657.72 | $576.61 | $510.54 | $435.41 | $404.32 | $194.43 | · | · | |
| Cash Flow / Share | $35.75 | $36.59 | $39.79 | $27.65 | $21.09 | $28.10 | $24.97 | $15.07 | · | · | |
| Cash / Share | $29.13 | $27.58 | $26.74 | $19.83 | $15.73 | $28.70 | $12.40 | $10.12 | · | · | |
| Dividend / Share | $6.04 | $5.60 | $4.92 | $4.48 | $4.00 | $0.04 | $0.04 | $0.04 | $0.04 | · | |
| EPS (TTM) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | · | 267,530,000 | 268,154,000 | 272,953,000 | · | 281,396,000 | 284,052,000 | 286,465,000 | · | 297,131,000 | 296,879,000 | 298,999,000 | · | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $271.51 | $259.43 | · | $260.71 | $250.52 | $239.98 | · | $226.35 | $213.07 | $199.87 | · | $165.07 | $163.66 | $155.58 | · | $147.24 | |
| Cash Flow / Share | · | $4.28 | · | · | · | $7.03 | · | · | · | $16.90 | · | · | · | $16.82 | · | · | |
| Dividend / Share | $1.56 | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.40 | $1.40 | $1.40 | $1.40 | $1.23 | $1.23 | $1.23 | $1.23 | $1.12 | $1.12 | |
| EPS (TTM) | $24.17 | $23.59 | · | $22.55 | $18.20 | $17.94 | · | $10.60 | $12.71 | $12.18 | · | $17.72 | $21.95 | $21.92 | · | $20.99 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $282.38B | $277.89B | · | $268.08B | $262.02B | $255.37B | · | $232.59B | $217.94B | $206.00B | · | $189.90B | $186.14B | $183.03B | · | $180.44B | |
| Net Income TTM | $6.23B | $6.10B | · | $6.02B | $4.87B | $4.97B | · | $3.14B | $3.77B | $3.65B | · | $5.49B | $6.82B | $6.88B | · | $6.70B | |
| P/E | 11.4 | 11.3 | · | 12.8 | 18.2 | 18.3 | · | 32.7 | 26.0 | 29.8 | · | 16.1 | 12.8 | 11.7 | · | 13.2 | |
| Earnings Yield | 8.8% | 8.8% | · | 7.8% | 5.5% | 5.5% | · | 3.1% | 3.8% | 3.4% | · | 6.2% | 7.8% | 8.6% | · | 7.6% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · | |
| Annual Payout | $1.62B | $1.62B | · | $1.60B | $1.59B | $1.58B | · | $1.54B | $1.51B | $1.48B | · | $1.43B | $1.41B | $1.40B | · | $1.37B |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Operating Margin % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| Diluted EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 1,871 filers · $73.0B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 160 (-31 vs prior Q) | 92 (-24 vs prior Q) | 684 (+29 vs prior Q) | 593 (+10 vs prior Q) | +5.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7,203,753,597 | 26,173,577 | 9.87% | Shares |
| BlackRock, Inc. | $6,461,456,854 | 23,438,250 | 8.85% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,762,729,281 | 17,276,296 | 6.53% | Shares |
| STATE STREET CORP | $3,496,245,161 | 12,682,259 | 4.79% | Shares |
| Dodge & Cox | $3,356,093,871 | 12,173,875 | 4.60% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $2,895,610,431 | 10,443,691 | 3.97% | Shares |
| Sanders Capital, LLC | $2,796,668,015 | 10,144,617 | 3.83% | Shares |
| FMR LLC | $2,210,454,198 | 8,018,189 | 3.03% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,720,317,832 | 6,268,347 | 2.36% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,717,104,307 | 6,228,614 | 2.35% | Shares |
| GQG Partners LLC | $1,628,918,123 | 5,908,707 | 2.23% | Shares |
| JPMORGAN CHASE & CO | $1,447,877,312 | 5,194,363 | 1.98% | Shares |
| MORGAN STANLEY | $1,017,483,597 | 3,690,812 | 1.39% | Shares |
| NORGES BANK | $982,164,860 | 3,562,699 | 1.35% | Shares |
| BANK OF AMERICA CORP /DE/ | $827,692,197 | 3,002,366 | 1.13% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785,495,575 | 2,849,302 | 1.08% | Shares |
| NORTHERN TRUST CORP | $752,795,794 | 2,730,687 | 1.03% | Shares |
| AMERIPRISE FINANCIAL INC | $719,183,166 | 2,608,447 | 0.99% | Shares |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710,448,797 | 2,577,075 | 0.97% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $692,582,460 | 2,512,025 | 0.95% | Shares |
| Invesco Ltd. | $662,627,873 | 2,403,612 | 0.91% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $656,057,221 | 2,459,446 | 0.90% | Shares |
| Davis Selected Advisers | $621,243,564 | 2,253,424 | 0.85% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600,668,400 | 2,178,861 | 0.82% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558,018,223 | 2,024,152 | 0.76% | Shares |
| Boston Partners | $555,607,176 | 2,014,660 | 0.76% | Shares |
| GOLDMAN SACHS GROUP INC | $548,715,710 | 1,990,408 | 0.75% | Shares |
| Legal & General Group Plc | $542,779,462 | 1,968,875 | 0.74% | Shares |
| TWO SIGMA INVESTMENTS, LP | $499,838,165 | 1,813,110 | 0.68% | Shares |
| Amundi | $472,966,222 | 1,715,636 | 0.65% | Shares |
| Bank of New York Mellon Corp | $450,936,717 | 1,635,725 | 0.62% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $409,669,412 | 1,476,499 | 0.56% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $409,373,497 | 1,484,959 | 0.56% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $396,029,634 | 1,436,556 | 0.54% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $396,005,041 | 1,436,453 | 0.54% | Shares |
| Nuveen, LLC | $372,070,579 | 1,349,647 | 0.51% | Shares |
| Capital World Investors | $365,436,721 | 1,325,583 | 0.50% | Shares |
| DEUTSCHE BANK AG\ | $352,569,909 | 1,278,910 | 0.48% | Shares |
| Capital Research Global Investors | $340,312,625 | 1,234,448 | 0.47% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $297,765,000 | 1,080,111 | 0.41% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295,639,232 | 1,072,400 | 0.41% | Call option |
| RAYMOND JAMES FINANCIAL INC | $285,021,252 | 1,033,884 | 0.39% | Shares |
| BloombergSen Inc. | $250,400,144 | 908,300 | 0.34% | Call option |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241,311,801 | 875,333 | 0.33% | Shares |
| Russell Investments Group, Ltd. | $233,022,643 | 844,481 | 0.32% | Shares |
| BRANDES INVESTMENT PARTNERS, LP | $232,489,133 | 843,317 | 0.32% | Shares |
| National Pension Service | $218,948,088 | 794,211 | 0.30% | Shares |
| UBS Group AG | $213,774,402 | 775,444 | 0.29% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $210,159,410 | 762,331 | 0.29% | Shares |
| Swiss National Bank | $205,012,464 | 743,661 | 0.28% | Shares |
Company insiders 41 insiders · 8 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Everett Neville | EVP, Special Advisor to the CEO | Sept. 3, 2026 S | 5,053 | 0 | 2 | $-671,895 |
| Brian C Evanko | President and Chief Executive Officer | Sept. 1, 2026 A | 41,030 | 0 | 1 | $-1,610,400 |
| David Cordani | Chairman & CEO | May 13, 2026 M | 57,766 | 1 | 13 | $-58,114,037 |
| Ann M Dennison | EVP, CFO | Feb. 27, 2026 A | 7,745 | 0 | 0 | $0 |
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | Aug. 18, 2026 S | 25,880 | 0 | 3 | $-6,784,615 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | Aug. 6, 2026 A | · | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | June 12, 2026 M | 2,368 | 0 | 1 | $-268,450 |
| Durga Prasad Koka | EVP, Global CIO | June 1, 2026 F | 6,552 | 0 | 0 | $0 |
| George Kurian | Director | Aug. 31, 2026 A | 4,560 | 0 | 0 | $0 |
| Neesha Hathi | Director | April 22, 2026 A | 4,151 | 0 | 0 | $0 |
| Philip Ozuah | Director | April 22, 2026 A | 2,583 | 0 | 0 | $0 |
| Mark B. Mcclellan | Director | April 22, 2026 A | 6,891 | 0 | 0 | $0 |
| Kimberly A. Ross | Director | April 22, 2026 A | 5,294 | 0 | 0 | $0 |
| Michael J Hennigan | Director | April 22, 2026 A | 1,350 | 0 | 0 | $0 |
| Kathleen M Mazzarella | Director | April 22, 2026 A | 6,891 | 0 | 0 | $0 |
| Donna F Zarcone | Director | April 22, 2026 A | 27,517 | 0 | 0 | $0 |
| Eric C Wiseman | Director | April 22, 2026 A | 23,940 | 0 | 0 | $0 |
| Eric J Foss | Director | April 22, 2026 A | 36,696 | 0 | 0 | $0 |
| David J Brailer | · | Aug. 29, 2025 F | 17,525 | 0 | 0 | $0 |
| Elder Granger | · | April 23, 2025 A | 6,109 | 0 | 0 | $0 |
| Noelle K Eder | · | March 7, 2025 S | 13,406 | 0 | 0 | $0 |
| Eric P Palmer | · | Feb. 28, 2025 A | 66,160 | 0 | 0 | $0 |
| William J Delaney III | · | Aug. 19, 2024 M | 17,539 | 0 | 0 | $0 |
| Michael W Triplett | · | Aug. 12, 2024 M | 32,833 | 0 | 0 | $0 |
| Mary T Hoeltzel | · | May 14, 2024 M | 2,595 | 0 | 0 | $0 |
| Cynthia Ryan | · | Aug. 30, 2023 M | 5,937 | 0 | 0 | $0 |
| Paul A Sanford | · | July 19, 2023 S | 8,679 | 0 | 0 | $0 |
| Jason D Sadler | · | Feb. 24, 2023 A | 47,015 | 0 | 0 | $0 |
| Charles Berg | · | Feb. 8, 2023 G | · | 0 | 0 | $0 |
| John Partridge | · | April 26, 2022 A | 28,177 | 0 | 0 | $0 |
| MURABITO JOHN M | · | March 1, 2022 F | 51,226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | · | Nov. 30, 2021 A | 20,015 | 0 | 0 | $0 |
| Matthew G Manders | · | Nov. 19, 2021 F | 43,488 | 0 | 0 | $0 |
| Timothy C Wentworth | · | May 12, 2021 G | 29,783 | 0 | 0 | $0 |
| Kristen Lauria | · | April 30, 2021 F | 2,785 | 0 | 0 | $0 |
| Steven B Miller | · | Feb. 26, 2021 F | 28,439 | 0 | 0 | $0 |
| William L Roper | · | Feb. 26, 2021 A | 8,583 | 0 | 0 | $0 |
| Roman Martinez IV | · | Nov. 30, 2020 A | 48,839 | 0 | 0 | $0 |
| Mark L Boxer | · | Feb. 28, 2020 F | 49,191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | · | Sept. 13, 2019 S | 13,500 | 0 | 0 | $0 |
| Lisa R Bacus | · | March 1, 2019 F | 24,024 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 156 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IHF · iShares Trust | 4.00% | 186,760 SH | Sept. 11, 2026 | Daily |
| DUSA · Davis Fundamental ETF Trust | 3.12% | 142,104 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.29% | 86,083 NS | July 31, 2026 | N-PORT |
| SMRI · EA Series Trust | 1.79% | 41,365 NS | July 31, 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1.76% | 6,426 SH | Oct. 1, 2026 | Daily |
| RPV · Invesco Exchange-Traded Fund Trust | 1.64% | 98,965 SH | Oct. 1, 2026 | Daily |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.60% | 51,281 SH | Oct. 1, 2026 | Daily |
| PWV · Invesco Exchange-Traded Fund Trust | 1.49% | 99,278 SH | Oct. 1, 2026 | Daily |
| NUDV · Nushares ETF Trust | 1.45% | 2,607 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1.42% | 506,293 SH | Oct. 1, 2026 | Daily |
| DWLD · Davis Fundamental ETF Trust | 1.36% | 29,890 NS | July 31, 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.19% | 89,148 SH | Oct. 1, 2026 | Daily |
| IYH · iShares Trust | 1.18% | 152,840 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 1.07% | 792,582 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 1.06% | 125,422 NS | July 31, 2026 | N-PORT |
| IMCV · iShares Trust | 1.00% | 41,404 SH | Sept. 11, 2026 | Daily |
| FFLV · FIDELITY COVINGTON TRUST | 0.97% | 573 NS | July 31, 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0.95% | 11,306 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.94% | 139,115 SH | Sept. 11, 2026 | Daily |
| RILA · Spinnaker ETF Series | 0.93% | 1,412 NS | July 31, 2026 | N-PORT |
| VLUE · iShares Trust | 0.90% | 308,315 SH | Sept. 11, 2026 | Daily |
| FBCV · FIDELITY COVINGTON TRUST | 0.88% | 5,567 NS | July 31, 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.88% | 30,767,177 | Oct. 1, 2026 | Daily |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.87% | 43,607 NS | July 31, 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.85% | 5,205 NS | July 31, 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.80% | 24,655 SH | Aug. 19, 2026 | Daily |
| EQIN · Columbia ETF Trust I | 0.77% | 8,375 NS | July 31, 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0.72% | 56,688 NS | July 31, 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0.69% | 2,953 SH | Oct. 1, 2026 | Daily |
| DFLV · Dimensional ETF Trust | 0.63% | 152,491 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.62% | 22,025 SH | Oct. 1, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.61% | 128,339 NS | July 31, 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.61% | 17,898,000 | Oct. 1, 2026 | Daily |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0.57% | 150,000 | Oct. 1, 2026 | Daily |
| FFLC · FIDELITY COVINGTON TRUST | 0.56% | 24,069 NS | July 31, 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0.55% | 28,136 NS | July 31, 2026 | N-PORT |
| FEUS · FlexShares Trust | 0.55% | 2,200 NS | July 31, 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0.53% | 1,744 NS | July 31, 2026 | N-PORT |
| IMCB · iShares Trust | 0.50% | 29,774 SH | Sept. 11, 2026 | Daily |
| QLC · FlexShares Trust | 0.48% | 17,472 NS | July 31, 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0.48% | 664 NS | July 31, 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.46% | 25,557 NS | July 31, 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.44% | 2,633 NS | July 31, 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.43% | 560,000 | Oct. 1, 2026 | Daily |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.42% | 19,474,000 | Oct. 1, 2026 | Daily |
| XOEF · iShares Trust | 0.42% | 331 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.37% | 206,037 NS | July 31, 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0.37% | 1,294 NS | July 31, 2026 | N-PORT |
| ESMV · iShares Trust | 0.37% | 102 SH | Sept. 11, 2026 | Daily |
| CATH · Global X Funds | 0.35% | 16,346 NS | July 31, 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0.34% | 166,268 SH | Aug. 19, 2026 | Daily |
| DGRO · iShares Trust | 0.33% | 509,486 SH | Sept. 11, 2026 | Daily |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.32% | 9,701 NS | July 31, 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0.32% | 52,531 NS | July 31, 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.31% | 111,655 SH | Oct. 1, 2026 | Daily |
| VYM · VANGUARD WHITEHALL FUNDS | 0.30% | 1,042,139 SH | Aug. 19, 2026 | Daily |
| EVUS · iShares Trust | 0.30% | 4,037 SH | Sept. 11, 2026 | Daily |
| DFVX · Dimensional ETF Trust | 0.28% | 5,359 NS | July 31, 2026 | N-PORT |
| IWX · iShares Trust | 0.27% | 37,789 SH | Sept. 11, 2026 | Daily |
| VTV · VANGUARD INDEX FUNDS | 0.27% | 2,516,218 SH | Aug. 19, 2026 | Daily |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.26% | 4,203 NS | July 31, 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.25% | 60,916 SH | Aug. 19, 2026 | Daily |
| IVE · iShares Trust | 0.25% | 438,897 SH | Sept. 11, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.25% | 20,149 NS | July 31, 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0.24% | 1,532 NS | July 31, 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.24% | 6,130 SH | Aug. 19, 2026 | Daily |
| IUSV · iShares Trust | 0.24% | 231,763 SH | Sept. 11, 2026 | Daily |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.23% | 6,639,000 | Oct. 1, 2026 | Daily |
| CHRI · Global X Funds | 0.22% | 64 NS | July 31, 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0.22% | 2,603 NS | July 31, 2026 | N-PORT |
| SUSL · iShares Trust | 0.22% | 9,336 SH | Sept. 11, 2026 | Daily |
| ACVF · ETF Opportunities Trust | 0.21% | 1,165 NS | July 31, 2026 | N-PORT |
| DSI · iShares Trust | 0.21% | 40,359 SH | Sept. 11, 2026 | Daily |
| ILCV · iShares Trust | 0.21% | 9,900 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.21% | 4,094 NS | July 31, 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.21% | 14,065 SH | Sept. 11, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 703,269 SH | Oct. 1, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.20% | 157,624 SH | Aug. 19, 2026 | Daily |
| IWD · iShares Trust | 0.20% | 580,231 SH | Sept. 11, 2026 | Daily |
| ACWV · iShares, Inc. | 0.19% | 23,190 SH | Sept. 11, 2026 | Daily |
| ESGU · iShares Trust | 0.19% | 122,944 SH | Sept. 11, 2026 | Daily |
| ROUS · Lattice Strategies Trust | 0.19% | 4,742 NS | July 31, 2026 | N-PORT |
| MPLY · Strategy Shares | 0.18% | 104 NS | July 31, 2026 | N-PORT |
| SIZE · iShares Trust | 0.18% | 2,691 SH | Sept. 11, 2026 | Daily |
| GLBL · Pacer Funds Trust | 0.18% | 7 NS | July 31, 2026 | N-PORT |
| USMV · iShares Trust | 0.17% | 144,573 SH | Sept. 11, 2026 | Daily |
| EGLE · Global X Funds | 0.17% | 13 NS | July 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.16% | 28,208 SH | Oct. 1, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.15% | 249,847 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.14% | 63,351 NS | July 31, 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0.14% | 52,742 SH | Aug. 19, 2026 | Daily |
| TOPC · iShares Trust | 0.14% | 159 SH | Sept. 11, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.13% | 8,098 SH | Oct. 1, 2026 | Daily |
| DIVB · iShares Trust | 0.13% | 9,546 SH | Sept. 11, 2026 | Daily |
| IWL · iShares Trust | 0.13% | 10,119 SH | Sept. 11, 2026 | Daily |
| XVV · iShares Trust | 0.13% | 3,041 SH | Sept. 11, 2026 | Daily |
| VV · VANGUARD INDEX FUNDS | 0.12% | 308,954 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.12% | 59,034 SH | Aug. 19, 2026 | Daily |
| XYLD · Global X Funds | 0.12% | 13,766 NS | July 31, 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0.12% | 9,915 NS | July 31, 2026 | N-PORT |
| ADME · ETF Series Solutions | 0.11% | 1,207 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.11% | 13,352 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.11% | 13,613 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.11% | 203 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.11% | 3,332,808 SH | Sept. 11, 2026 | Daily |
| BKLC · BNY Mellon ETF Trust | 0.11% | 21,844 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.11% | 255 NS | July 31, 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.11% | 1,573 SH | Oct. 1, 2026 | Daily |
| XTR · Global X Funds | 0.11% | 19 NS | July 31, 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.11% | 35,099 NS | July 31, 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.11% | 6,870,735 SH | Aug. 19, 2026 | Daily |
| TOV · EA Series Trust | 0.11% | 1,059 NS | July 31, 2026 | N-PORT |
| XCLR · Global X Funds | 0.11% | 14 NS | July 31, 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.11% | 4,302 NS | July 31, 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.11% | 45,656 SH | Oct. 1, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.11% | 80,995 NS | July 31, 2026 | N-PORT |
| ILCB · iShares Trust | 0.11% | 4,927 SH | Sept. 11, 2026 | Daily |
| IYY · iShares Trust | 0.11% | 11,380 SH | Sept. 11, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.11% | 998 NS | July 31, 2026 | N-PORT |
| IWB · iShares Trust | 0.10% | 180,235 SH | Sept. 11, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.10% | 6,372 NS | July 31, 2026 | N-PORT |
| ESG · FlexShares Trust | 0.10% | 480 NS | July 31, 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0.10% | 21 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.10% | 343,920 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.10% | 71,744 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.10% | 8,400,121 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.10% | 43,269 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.10% | 21,990 SH | Aug. 19, 2026 | Daily |
| LGDX · Tidal Trust III | 0.10% | 497 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.09% | 7,268 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 2,686 SH | Oct. 1, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.09% | 209 SH | Oct. 1, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.09% | 1,842 NS | July 31, 2026 | N-PORT |
| TOK · iShares Trust | 0.09% | 744 SH | Sept. 11, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.09% | 20,684 NS | July 31, 2026 | N-PORT |
| URTH · iShares, Inc. | 0.08% | 23,813 SH | Sept. 11, 2026 | Daily |
| LRGF · iShares Trust | 0.08% | 10,058 SH | Sept. 11, 2026 | Daily |
| ACWI · iShares Trust | 0.07% | 83,068 SH | Sept. 11, 2026 | Daily |
| USCL · iShares Trust | 0.07% | 6,976 SH | Sept. 11, 2026 | Daily |
| NULC · Nushares ETF Trust | 0.06% | 152 NS | July 31, 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.06% | 219,986 SH | Aug. 19, 2026 | Daily |
| GLOF · iShares Trust | 0.02% | 150 SH | Sept. 11, 2026 | Daily |
| PEVC · Pacer Funds Trust | 0.01% | 1 NS | July 31, 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 109,800 | Oct. 1, 2026 | Daily |
| GTOS · Invesco Actively Managed Exchange-T… | 0.00% | 400 | Sept. 30, 2026 | Daily |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| VCEB · VANGUARD WORLD FUND | · | · | July 30, 2026 | Daily |
CI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
24 analysts · 2026-10-02Mean target $342.29 +26.5%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.